BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 31604786)

  • 1. Perspectives of health professionals towards deprescribing practice in Asian nursing homes: a qualitative interview study.
    Kua CH; Mak VS; Lee SWH
    BMJ Open; 2019 Oct; 9(10):e030106. PubMed ID: 31604786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and Enablers of Deprescribing: A General Practitioner Perspective.
    Ailabouni NJ; Nishtala PS; Mangin D; Tordoff JM
    PLoS One; 2016; 11(4):e0151066. PubMed ID: 27093289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unlocking Deprescribing Potential in Nursing Homes: Insights from a Focus Group Study with Healthcare Professionals.
    Visser AGR; de-Bruijn JBGP; Spaetgens B; Winkens B; Janknegt R; Schols JMGA
    Drugs Aging; 2024 Mar; 41(3):261-270. PubMed ID: 38285238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nursing Home Residents' Thoughts on Discussing Deprescribing of Preventive Medications.
    Thompson W; Jacobsen IT; Jarbøl DE; Haastrup P; Nielsen JB; Lundby C
    Drugs Aging; 2020 Mar; 37(3):187-192. PubMed ID: 31997117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "I simply don't know, because I don't know which drugs I get": Perspectives on deprescribing among older adults with limited life expectancy and their relatives.
    Graabaek T; Lundby C; Ryg J; Søndergaard J; Pottegård A; Nielsen DS
    Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):115-127. PubMed ID: 32770703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivering the right information to the right person at the right time to facilitate deprescribing in hospital: a mixed methods multisite study to inform decision support design in Australia.
    Baysari MT; Duong M; Zheng WY; Nguyen A; Lo S; Ng B; Ritchie A; Le Couteur D; McLachlan A; Bennett A; Hilmer S
    BMJ Open; 2019 Sep; 9(9):e030950. PubMed ID: 31562155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicians', Nurses' and Pharmacists' Perceptions of Determinants to Deprescribing in Nursing Homes Considering Three Levels of Action: A Qualitative Study.
    Foley RA; Hurard LL; Cateau D; Koutaissoff D; Bugnon O; Niquille A
    Pharmacy (Basel); 2020 Feb; 8(1):. PubMed ID: 32046022
    [No Abstract]   [Full Text] [Related]  

  • 8. "… Above All, It's a Matter of  This Person's Quality of Life": Health Care Professionals' Perspectives on Deprescribing in Older Patients With Limited Life Expectancy.
    Lundby C; Graabæk T; Ryg J; Søndergaard J; Pottegård A; Nielsen DS
    Gerontologist; 2020 Apr; 60(3):439-449. PubMed ID: 31433836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study.
    Rowe S; Pittman N; Balsom C; Druken R; Kelly DV
    Int J Clin Pharm; 2022 Dec; 44(6):1370-1379. PubMed ID: 36201111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of home care nurse's experiences in deprescribing of medications: a qualitative descriptive study.
    Sun W; Tahsin F; Barakat-Haddad C; Turner JP; Haughian CR; Abbass-Dick J
    BMJ Open; 2019 May; 9(5):e025606. PubMed ID: 31129579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist-led deprescribing in care homes.
    Birt L; Wright DJ; Blacklock J; Bond CM; Hughes CM; Alldred DP; Holland R; Scott S
    Health Soc Care Community; 2022 Nov; 30(6):e6521-e6531. PubMed ID: 36336895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare professionals' perspectives of deprescribing in older patients at the end of life in hospice care: a qualitative study using the Theoretical Domains Framework.
    Alwidyan T; McCorry NK; Parsons C
    Int J Pharm Pract; 2023 May; 31(3):305-313. PubMed ID: 36866441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nursing home team-care deprescribing study: a stepped-wedge randomised controlled trial protocol.
    Kua CH; Yeo CYY; Char CWT; Tan CWY; Tan PC; Mak VS; Lee SWH; Leong IY
    BMJ Open; 2017 May; 7(5):e015293. PubMed ID: 28490560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge and willingness of physicians about deprescribing among older patients: a qualitative study.
    AlRasheed MM; Alhawassi TM; Alanazi A; Aloudah N; Khurshid F; Alsultan M
    Clin Interv Aging; 2018; 13():1401-1408. PubMed ID: 30122912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.
    Alharthi M; Wright D; Scott S; Birt L
    Res Social Adm Pharm; 2023 May; 19(5):746-752. PubMed ID: 36732210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes towards deprescribing: The perspectives of geriatric patients and nursing home residents.
    Lundby C; Glans P; Simonsen T; Søndergaard J; Ryg J; Lauridsen HH; Pottegård A
    J Am Geriatr Soc; 2021 Jun; 69(6):1508-1518. PubMed ID: 33598916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of interprofessional quality circles on deprescribing in Swiss nursing homes: an observational study.
    Mena S; Moullin JC; Schneider M; Niquille A
    BMC Geriatr; 2023 Oct; 23(1):620. PubMed ID: 37789286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis.
    Langford AV; Gnjidic D; Lin CC; Bero L; Penm J; Blyth FM; Schneider CR
    BMJ Qual Saf; 2021 Feb; 30(2):133-140. PubMed ID: 32220937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of implementing deprescribing for older adults in English care homes: a qualitative interview study.
    Warmoth K; Rees J; Day J; Cockcroft E; Aylward A; Pollock L; Coxon G; Craig T; Walton B; Stein K
    BMJ Open; 2023 Nov; 13(11):e081305. PubMed ID: 37996237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicians' views on pharmacists' involvement in hospital deprescribing: A qualitative study on proton pump inhibitors.
    Gendre P; Mayol S; Mocquard J; Huon JF
    Basic Clin Pharmacol Toxicol; 2023 Dec; 133(6):718-728. PubMed ID: 37081726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.